Using Applied BioMath Assess™ to Predict Pharmacology and Align Stakeholders

This case study highlights the ways in which Applied BioMath Assess™ can be used for early feasibility assessment to predict the PK and pharmacology of a hypothetical monoclonal antibody. It explores a situation in which early feasibility assessment supports decision making and describes how insights can drive alignment during drug discovery.


Download the Video

Resource Type